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Abstract: Linear basal cell carcinoma (BCC), which has a ratio of its long and short axes of more than 3: 1, is a distinct 
clinical entity among BCC. We report the first case report of a linear BCC in an Asian patient. An 87 year-old woman 
presented with an ulcerated black nodule, 155mm (3: 1), on her nasojungal fold of the right lower eyelid. The tumor was 
excised with 5 mm safety margin. The pathological examination confirmed the tumor was a BCC with a clear margin. Di-
agnosis of a linear BCC is based on its morphological features and occurrence along the wrinkle line, which needs to be 
also considered in Asian. 
INTRODUCTION 
  Linear basal cell carcinoma (BCC), first reported in 
1985, is a definite clinical entity among BCC [1]. It shows a 
linear form along a wrinkle line [2] and the proportion of its 
long and short axes is more than 3: 1 [3,4]. The most usual 
sites for it to occur are the lower eyelid, cheek and neck ar-
eas [1,3-6]. Although 33 cases have been reported so far, to 
our knowledge, there are no reports of its occurrence in 
Asians [1,3-6]. 
  Most linear BCC microscopically show a “nodular” sub-
type, and have low recurrence [3,4,6], which is similar to 
BCC in general [8-10]. However, 25 to 40% of linear BCC 
demonstrate high risk subtypes with a high recurrence rates, 
such as micronodular, infiltrative and morpheic subtypes 
[3,4,7]. Since only 6% of all BCC are high risk types, linear 
BCC has a high possibility of being a high risk subtype [7]. 
This is a reason that linear BCC is judged as a definite clini-
cal entity among BCC [3,4]. Therefore, meticulous care 
needs to be taken with linear BCC during follow up periods 
[7,8]. 
  We here report a case of a linear BCC that occurred on 
the nasojugal fold of the right lower eyelid. This is the first 
case report of a linear BCC involving an Asian patient. 
CASE REPORT 
  An 87 year-old woman presented with an ulcerated black 
nodule, 15 x 5 mm (3: 1), on nasojugal fold of the right 
lower eyelid (Fig. 1). Her lower eyelid was everted toward 
the tumour because of the traction and the lateral margin of 
the tumour was situated to around the half of the lower eye-
lid. Computed tomography did not show any spread to deep 
orbital structures or to bone. Based on these clinical findings, 
a linear BCC was suspected. The tumour was excised with a 
5 mm safety margin, and the traction of the skin was   
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Fig. (1). A black ulcerated nodule, 15 x 5 mm (3: 1), can be seen on 
the nasojungal fold of the right lower eyelid. The lower eyelid 
shows medial ectropion and the lateral margin of it is situated to 
around the half of the lower eyelid. 
completely released, after which the defect of the tumour 
became very large (Fig. 2). The defect was reconstructed 
with a cheek rotation flap for the lower eyelid area and a 
nasolabial VY advancement flap for the medial canthal area 
(Fig. 3). The upper lacrimal outflow system could be left, 
and by reconstructing the lower eyelid suspending laterally, 
the lower eyelid slope toward nasally was made to flow the 
lacrimal fluid. The pathological diagnosis was “BCC (nodu-
lar type)” with a clear margin (Fig. 4). No perineural and 
vascular invasion was noted. Postoperatively, although the 
patient felt a little epiphora, its extent was not so severe. No 
recurrence or metastasis was found within the following 12 
months (Fig. 5). 
DISCUSSION 
  We have reported the first case of a linear BCC in an 
Asian patient. In general, malignant skin tumours are well  
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Fig. (2). The linear basal cell carcinoma was excised with 5 mm 
safety margin. As the skin had been pulled toward the tumour, 
when the traction was released, the defect became very large. 
 
Fig. (3). The defect was reconstructed with a cheek rotation flap for 
the lower eyelid area and a nasolabial VY advancement flap for the 
medial canthal area. 
seen in White patients with a lot of sun exposure [11]. On 
the other hand in Asians, occurrence of the malignant skin 
tumours is much less than the White population [11]. There-
fore, it is important to understand that Asians can take a 
same entity. 
  BCC is the most common human malignancy and macro-
scopically can be divided into 3 main subtypes: noduloul-
cerative, superficial and sclerosing (morpheaform) [1]. Since 
these 3 subtypes have various appearances, only 60 to 70% 
of clinical diagnoses correspond with the pathological diag-
nosis [12]. However, as linear BCC show a peculiar linear 
form along a wrinkle line [1,3-6], confident clinical diagno-
sis is possible. The present tumour clinically demonstrated a 
typical noduloulcerative subtype and occurred along the na-
sojugal wrinkle line, which enabled us to diagnose it easily. 
  The first choice therapy for BCC is surgical excision 
[13]; the same for linear BCC [1,3-6]. Here, we established a 
safety margin of 5 mm and so obtained a clear margin. This 
was based on evidence that 95% of BCC, except for the scle-
rosing (morpheaform) subtype, of less than 20 mm diameter 
show a clear margin if there is a safety margin of 5 mm [12]. 
Although the frozen section control and the Mohs’ micro- 
 
 
 
 
Fig. (4). Pathological specimen (Hematoxylin and Eosin). Typical 
“nodular” subtype is demonstrated. a. Tiny tumor islands are dem-
onstrated. (bar = 200 μm) b. The magnification of the rectangle in 
a. Palisading (allow) and clefting (star) are shown. (bar = 100 μm) 
 
Fig. (5). Postoperative findings show no local recurrence or lower 
eyelid ectropion. By reconstructing the lower eyelid suspending 
laterally, the lower eyelid slope toward nasally was made to flow 
the lacrimal fluid. 
graphic surgery are the most common procedure for excision 
of a BCC [11,14], a procedure with a safety margin of 5 mm 
also assures a low recurrent rate of 1.3% to 3% [15,16]. 
Standard 5 mm margins can lead to incomplete excision in a 
proportion of cases, but it is useful when the frozen section 22    The Open Ophthalmology Journal, 2007, Volume 1  Shinsuke et al. 
control or the Mohs’ micrographic surgery cannot be under-
taken. 
CONCLUSIONS 
  This is the first report of a linear BCC in an Asian pa-
tient. Diagnosis of linear BCC is based on its morphological 
features and occurrence along the wrinkle line, which needs 
to be also considered in Asian. 
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